SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-067024
Filing Date
2023-08-14
Accepted
2023-08-14 16:06:57
Documents
46
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0623_citiuspharma.htm   iXBRL 10-Q 507329
2 CERTIFICATION f10q0623ex31-1_citiuspharma.htm EX-31.1 10082
3 CERTIFICATION f10q0623ex31-2_citiuspharma.htm EX-31.2 10104
4 CERTIFICATION f10q0623ex32-1_citiuspharma.htm EX-32.1 5291
  Complete submission text file 0001213900-23-067024.txt   3439229

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ctxr-20230630.xsd EX-101.SCH 49701
6 XBRL CALCULATION FILE ctxr-20230630_cal.xml EX-101.CAL 28755
7 XBRL DEFINITION FILE ctxr-20230630_def.xml EX-101.DEF 177528
8 XBRL LABEL FILE ctxr-20230630_lab.xml EX-101.LAB 387271
9 XBRL PRESENTATION FILE ctxr-20230630_pre.xml EX-101.PRE 189874
40 EXTRACTED XBRL INSTANCE DOCUMENT f10q0623_citiuspharma_htm.xml XML 311289
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38174 | Film No.: 231169956
SIC: 2834 Pharmaceutical Preparations